Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targeting multiple indications, including cancer. In the past week, the company’s stock lost 57.5%. This ...
Gritstone bio (NASDAQ:GRTS) was downgraded by both Jones Research and B. Riley on Wednesday, the day after the stock cratered in the wake of mixed data for Gritstone’s GRANITE cancer vaccine and news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results